Skip to main content
Intrasense logo

Intrasense — Investor Relations & Filings

Ticker · ALINS ISIN · FR0011179886 LEI · 969500VF6MOVQXWHAE33 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 310 across all filing types
Latest filing 2024-02-21 Regulatory Filings
Country FR France
Listing PA ALINS

About Intrasense

https://www.intrasense.fr/

Intrasense, a subsidiary of the Guerbet Group, is a medical technology company that develops and markets advanced software solutions for medical imaging. Its flagship product, the Myrian® platform, is a comprehensive visualization tool that assists healthcare professionals in reviewing and analyzing 2D and 3D medical images from modalities such as MRI and CT scanners. The company's solutions are characterized by the native integration of Artificial Intelligence (AI) algorithms to enhance diagnostic accuracy and workflow efficiency. Intrasense also offers specialized solutions, including Liflow® for oncology imaging and the DUOnco™ suite of AI tools for lesion detection. The technology aims to facilitate and secure clinical diagnosis, decision-making, and therapeutic monitoring for radiologists and other clinicians.

Recent filings

Filing Released Lang Actions
Intrasense annonce la certification de Myrian® au nouveau règlement européen (MDR)
Regulatory Filings Classification · 100% confidence The document announces that Intrasense has obtained a new CE certificate under MDR (Medical Device Regulation) for its Myrian® software solution. This is a specific operational update regarding regulatory compliance and product commercialization authorization, not a standard periodic financial report (like 10-K or IR), an earnings release (ER), or a management discussion (MDA). It is an announcement concerning a significant regulatory milestone that impacts the company's ability to operate and grow in the European market. Since it is not a standard financial filing, nor a director dealing, dividend notice, or capital change, it best fits the general category for regulatory announcements that don't fit elsewhere, which is Regulatory Filings (RNS). Although it is a specific regulatory achievement, RNS serves as the appropriate catch-all for non-standard regulatory news releases.
2024-02-21 French
Intrasense annonce son chiffre d’affaires annuel 2023
Earnings Release Classification · 100% confidence The document is titled "Intrasense annonce son chiffre d'affaires annuel 2023" (Intrasense announces its 2023 annual revenue) and provides detailed consolidated revenue figures (Chiffre d'affaires) for the full year 2023, broken down by semester and geography. It explicitly mentions the figures are 'non certifié' (unaudited) but relates to the full year performance. This content structure—announcing annual financial results, including key figures and commentary on performance drivers—is characteristic of an Earnings Release (ER). While it covers the full year, it is presented as an immediate announcement of the results, not the comprehensive, audited 10-K filing. It is too detailed for a simple Report Publication Announcement (RPA) and is clearly focused on the financial results themselves. FY 2023
2024-02-08 French
Intrasense annonce son agenda financier pour l’année 2024
Report Publication Announcement Classification · 99% confidence The document text is extremely short (417 characters) and contains only contact information for investor relations and a brief 'About Intrasense' section, along with a placeholder table. It does not contain substantive financial data, management changes, or detailed regulatory disclosures. Given its brevity and lack of specific content matching the defined categories (like 10-K, ER, or IP), it most closely resembles a general informational notice or a placeholder/cover page. Since it doesn't announce a specific event (like a dividend or AGM) or a report publication, the most appropriate fallback category for a very brief, non-substantive regulatory or informational document is 'Regulatory Filings' (RNS), although it could also be considered a very minimal 'Fund Information / Factsheet' (FS) if it were intended as a summary, but RNS is safer for miscellaneous short filings.
2024-01-31 French
Intrasense annonce un partenariat stratégique avec EDL, leader français des solutions de santé numériques
M&A Activity Classification · 99% confidence The document is a press release announcing a strategic partnership between Intrasense and EDL regarding medical imaging software integration. It is dated October 18th and provides details about the collaboration, market positioning, and quotes from management. This type of announcement, detailing a significant business development (partnership/alliance) that is not a standard financial filing (like 10-K, ER, or IR), typically falls under general regulatory announcements or news releases. Since there is no specific category for 'Partnership Announcement' and it is not a standard financial report, it is best classified as a general Regulatory Filing (RNS) or potentially a Legal/Transaction related filing if the partnership involved a major asset transfer, but RNS is the most appropriate fallback for non-standard corporate news releases.
2023-10-18 French
INTRASENSE et CASIS signent un contrat pour la distribution d’une solution d’IA cardiaque
Regulatory Filings Classification · 100% confidence The document is a press release dated October 9, 2023, announcing a partnership agreement between Intrasense and CASIS for the distribution of an AI cardiac solution in the Chinese market. This type of announcement, detailing a strategic business agreement, partnership, or contract signing, does not fit neatly into the specific financial reporting categories (like 10-K, ER, IR) or standard corporate actions (like DIV, SHA, DIRS). It is a general business update. Given the available options, the most appropriate classification for a significant, non-standard regulatory or financial announcement that doesn't fit elsewhere is 'Regulatory Filings' (RNS), which serves as a general announcement category, or potentially 'Capital/Financing Update' (CAP) if the partnership involved significant capital structuring, but the text focuses purely on distribution and technology integration. Since it is a general corporate announcement about a business development, RNS is the best fit as a catch-all for significant, non-standard news releases.
2023-10-09 French
Résultats semestriels 2023 : croissance du chiffre d’affaires et poursuite de la politique d’investissement
Earnings Release Classification · 99% confidence The document contains detailed, comparative financial tables titled "Compte de résultat consolidé simplifié" (Simplified consolidated income statement) and "Principaux éléments bilanciels consolidés" (Main consolidated balance sheet items) for the period ending June 30, 2023, compared to June 30, 2022. It explicitly mentions that the financial statements for the semester ended June 30, 2023, were reviewed by the statutory auditor and approved by the Board of Directors on September 15, 2023. Furthermore, it refers to the document as the "Rapport financier semestriel 2023" (Half-year financial report 2023) and discusses "Résultats semestriels 2023" (Half-year results 2023). This content structure and terminology strongly indicate a comprehensive financial report covering a period shorter than a year (a half-year report). This aligns perfectly with the definition of an Interim / Quarterly Report (IR). H2 2023
2023-09-20 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.